Schedule 13D ownership disclosure

ReShape Lifesciences Inc.

Security class unavailable · CUSIP: 76090R101

Event date: 2023-02-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
27.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000897069-23-000114
Form type
SC 13D
Filer
FOLEY & LARDNER/ FA
CIK
CIK 897069
Filed
Feb 15, 2023
Reporting period
Feb 06, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub